5 theme stocks in the Cancer Research theme, with a combined market value of $1.11T. On average they are up 0.20% today and up 47% over the past year.
Biggest gainers in this group
Biggest decliners in this group
How many members are up or down right now
3 advancing · 2 declining · 0 unchanged
| # | Stock | Price | Day | 1 year | Market cap | P/E | Yield | 52-week range |
|---|---|---|---|---|---|---|---|---|
| 1 | MRK Merck & Co | $148.64 | ▲ 0.38% | ▲ 96.9% | $366.72B | 20.4 | 2.26% | |
| 2 | NVS Novartis AG | $143.71 | ▲ 0.70% | ▲ 20.7% | $273.15B | 20.1 | 3.30% | |
| 3 | GILD Gilead Sciences | $150.74 | ▼ 0.42% | ▲ 40.5% | $186.91B | 22.2 | 2.14% | |
| 4 | PFE Pfizer | $28.48 | ▲ 1.05% | ▲ 26.8% | $162.27B | 20.9 | 6.04% | |
| 5 | BMY Bristol-Myers Squibb | $60.72 | ▼ 0.71% | ▲ 49.5% | $124.02B | 17.5 | 4.13% |
"1 year" is the price change over the past 365 days. P/E is trailing. For reference only, not investment advice.